Loading…

Peginterferon α-2a (40kD) [Pegasys®] improves HR-QOL outcomes compared with unmodified interferon α-2a [Roferon®-A]: In patients with chronic hepatitis C

Saved in:
Bibliographic Details
Published in:PharmacoEconomics 2003, Vol.21 (5), p.341-349
Main Authors: RASENACK, Jens, ZEUZEM, Stefan, AMY LIN, WINTFELD, Neil, GREEN, Jesse, FEINMAN, S. Victor, HEATHCOTE, E. Jenny, MANNS, Michael, YOSHIDA, Eric M, SWAIN, Mark G, GANE, Edward, DIAGO, Moises, REVICKI, Dennis A
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1170-7690
1179-2027
DOI:10.2165/00019053-200321050-00005